Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MSM Protein Technologies is a specialized biotechnology company focused on the discovery of functional monoclonal antibodies against complex, multi-spanning membrane proteins, including G protein-coupled receptors (GPCRs), ion channels, and transporters. The company utilizes its proprietary M-S-M (Multi-Spanning Membrane) protein platform, which enables the production of high-concentration, purified, and correctly folded membrane proteins for use as antigens. This technology overcomes the traditional difficulties associated with these targets, such as low expression levels and structural instability outside the lipid bilayer. MSM Protein Technologies primarily operates through strategic collaborations with major pharmaceutical companies, providing expertise in antigen design, immunization, and antibody screening. Their discovery engine supports the development of novel therapeutics for oncology, inflammation, and metabolic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MSM Protein Technologies.